CCIA
AZN icon

Campbell & Co Investment Adviser’s AstraZeneca AZN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43M Buy
29,025
+20,687
+248% +$3.89M 0.28% 66
2026
Q1 		$1.62M Buy
+8,338
New +$1.61M 0.09% 340
2025
Q4 		– Sell
-19,409
Closed -$2.98M – 1136
2025
Q3 		$2.98M Buy
19,409
+2,194
+13% +$332K 0.23% 100
2025
Q2 		$2.41M Sell
17,215
-11,669
-40% -$1.64M 0.15% 197
2025
Q1 		$4.25M Buy
28,884
+20,756
+255% +$3M 0.33% 54
2024
Q4 		$1.07M Sell
8,128
-26,667
-77% -$3.73M 0.08% 367
2024
Q3 		$5.42M Buy
+34,795
New +$5.62M 0.4% 29
2024
Q1 		– Sell
-7,648
Closed -$1.03M – 1102
2023
Q4 		$1.03M Sell
7,648
-247
-3% -$32.1K 0.09% 379
2023
Q3 		$1.07M Buy
+7,895
New +$1.08M 0.13% 244
2023
Q2 		– Sell
-6,858
Closed -$952K – 876
2023
Q1 		$952K Buy
+6,858
New +$923K 0.18% 173
2022
Q4 		– Sell
-30,230
Closed -$3.32M – 765
2022
Q3 		$3.32M Buy
+30,230
New +$3.83M 0.75% 3
2016
Q1 		– Sell
-3,100
Closed -$210K – 124
2015
Q4 		$210K Buy
+3,100
New +$203K 1.4% 44
2014
Q3 		– Sell
-49,272
Closed -$3.66M – 190
2014
Q2 		$3.66M Buy
49,272
+42,072
+584% +$3.04M 1.46% 19
2014
Q1 		$467K Buy
+7,200
New +$465K 0.19% 137

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Campbell & Co Investment Adviser's AZN Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its AstraZeneca (AZN) stake by 248% in Q2 2026, buying an estimated $3.89M and bringing the position to 29,025 shares worth $5.43M. The position accounts for 0.28% of the portfolio, ranked #66.

Campbell & Co Investment Adviser first reported a position in AZN in Q1 2014 and has held it in 14 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Campbell & Co Investment Adviser held 29,025 shares of AstraZeneca worth $5.43M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 20,687 AstraZeneca shares in Q2 2026, an estimated $3.89M.
  • AstraZeneca made up 0.28% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #66 holding.
  • Campbell & Co Investment Adviser first reported a position in AstraZeneca in Q1 2014 and has held it in 14 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.